IPI/PD1 Sequential Studies: Update of locations Home › Forums › Melanoma Diagnosis: Stage IV › IPI/PD1 Sequential Studies: Update of locations This topic is empty. Viewing 1 post (of 1 total) Author Posts September 4, 2013 at 2:16 pm #21556 Catherine PooleKeymaster Patients enrolled in the study will be randomized to one of 3 treatment arms. Patients randomized to Arm A will receive nivolumab every 2 weeks until disease progression. Patients on Arm B will receive nivolumab combined with ipilimumab every 3 weeks for 4 doses followed by nivolumab alone every 3 weeks until disease progression. Patients randomized to Arm C will receive ipilimumab monotherapy every 3 weeks for a total of 4 doses. For study locations near you, please email me as the list is too extensive to post: firstname.lastname@example.org. You must be treatment naïve (no previous treatment) Author Posts Viewing 1 post (of 1 total) The forum ‘Melanoma Diagnosis: Stage IV’ is closed to new topics and replies.